TP53 and breast cancer: In co-immunoprecipitation experiments, we also showed that X15695 disrupted the interaction of BAG2 but not BAG5 with mutant p53 in the T47D cells (Fig. 5C), pointing to a possible action of X15695 in the disruption of BAG/p53 complexes in breast cancer cells.